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Abstract
Background: Because no single person or group holds knowledge about all aspects of research, mechanisms are
needed to support knowledge exchange and engagement. Expertise in the research setting necessarily includes
scientific and methodological expertise, but also expertise gained through the experience of participating in
research and/or being a recipient of research outcomes (as a patient or member of the public). Engagement is, by
its nature, reciprocal and relational: the process of engaging research participants, patients, citizens and others (the
many ‘publics’ of engagement) brings them closer to the research but also brings the research closer to them.
When translating research into practice, engaging the public and other stakeholders is explicitly intended to make
the outcomes of translation relevant to its constituency of users.
Methods: In practice, engagement faces numerous challenges and is often time-consuming, expensive and ‘thorny’
work. We explore the epistemic and ontological considerations and implications of four common critiques of
engagement methodologies that contest: representativeness, communication and articulation, impacts and
outcome, and democracy. The ECOUTER (Employing COnceptUal schema for policy and Translation Engagement in
Research) methodology addresses problems of representation and epistemic foundationalism using a methodology
that asks, “How could it be otherwise?” ECOUTER affords the possibility of engagement where spatial and temporal
constraints are present, relying on saturation as a method of ‘keeping open’ the possible considerations that might
emerge and including reflexive use of qualitative analytic methods.
Results: This paper describes the ECOUTER process, focusing on one worked example and detailing lessons learned
from four other pilots. ECOUTER uses mind-mapping techniques to ‘open up’ engagement, iteratively and
organically. ECOUTER aims to balance the breadth, accessibility and user-determination of the scope of
engagement. An ECOUTER exercise comprises four stages: (1) engagement and knowledge exchange; (2) analysis of
mindmap contributions; (3) development of a conceptual schema (i.e. a map of concepts and their relationship);
and (4) feedback, refinement and development of recommendations.
Conclusion: ECOUTER refuses fixed truths but also refuses a fixed nature. Its promise lies in its flexibility,
adaptability and openness. ECOUTER will be formed and re-formed by the needs and creativity of those who use it.
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Translation
* Correspondence: madeleine.murtagh@bristol.ac.uk
1Data2Knowledge (D2K) Research Group, School of Social and Community
Medicine, University of Bristol, Bristol, UK
2Centre for Policy, Ethics and Life Sciences (PEALS), Newcastle University,
Newcastle, UK
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Murtagh et al. BMC Medical Ethics  (2017) 18:24 
DOI 10.1186/s12910-017-0167-z
Background
Translational research, stakeholder engagement and
genomics
In describing an “ethos and ethics of translation”,
Maienschein and colleagues [1] position the rise of
translational research in terms of historical transforma-
tions in the social contract regarding publicly funded re-
search; specifically, a shift from one in which public
investment in science produces public benefit through-
out the scientific enterprise as a whole, to one in which
funding is tied to demonstrable potential for outcomes
and where the public (reasonably) expect scientists to
deliver results. In this newer context they ask us to con-
sider, “Who decides what count as results? And who de-
cides which science will best get us the results desired?
Who decides what to translate, how to do the translation,
and when something counts as having been successfully
translated? And on what basis (justifiable or not) are
any of these decisions made?” [p. 46]. In opening up the
question of “Who decides?”, they point also to the over-
whelming shift in contemporary science and society re-
garding expectations about who are the relevant
stakeholders of today’s science. In a similar way, Callard
and colleagues [2] prompt us to ask social, ethical and
political questions about the outputs of translational re-
search: Are they available? Are they needed? Do they fit
peoples’ lives? In their user/patient-centric model of
translational research the authors point us to the
identity-producing effects of translational research, ask-
ing us to heed Singh and Rose [3] (among others) in in-
volving all those affected by the outputs of research
before its translation into practice. Engaging the many
‘publics’ who have a stake in decisions about transla-
tional outcomes offers one way of ensuring Callard’s
questions are aired.
Because no single person or group holds knowledge
about all aspects of research, mechanisms are needed to
support knowledge exchange and engagement. More-
over, as Burgess [4] notes, there has been a distinctive
shift in thinking about governance of bioscience and bio-
technology from one in which publics are viewed as
needing education about science to one which considers
public engagement in the co-production of policy and
decision making as offering important local knowledge
and expertise. Expertise in the research setting necessar-
ily includes scientific and methodological expertise, but
also expertise gained through the experience of partici-
pating in research and/or being a recipient of research
outcomes (as a patient or member of the public). There
is, indeed, a long-standing history of engaging publics
and other stakeholders in the varieties of ’omics re-
search; a history as long as the Human Genome project
itself. Some of these are bottom-up, led by varying pub-
lics, and across boundaries with citizen-science; others
comprise what might be called engagement by invitation
[5, 6]. It is this latter strategy that is the focus of this
paper. And there are many examples of good practice,
particularly using deliberative approaches to bring to-
gether members of the public with experts in the rele-
vant field [4, 7–23]. While there are many ways to
implement deliberative processes [9], in genomics they
have typically involved small numbers of participants
(up to 25) selected to broadly represent the make-up of
the (local) general population; they take place over one
or more intensive periods of time; include provision of
background material to help participants think through
a range of matters and perspectives related to the issues
under discussion and the opportunity to interact with
and question experts. The output of deliberative engage-
ment is generally the production of recommendations
on the issue under discussion.
In ethical terms, exercises in engagement are variously
understood as a form of democracy, an act of respect,
and an acknowledgement of human rights, including the
right to self-determination and the right to be involved
in decisions that affect one’s life and life-world [24–30].
The aspiration of such engagement is to improve the
alignment of research, healthcare and governmental
practices more generally with societal values, and to im-
prove delivery and relevance of services and research
outputs or translation. Engagement is, by its nature, re-
ciprocal and relational: the process of engaging research
participants, patients, citizens and others (what might be
considered the many ‘publics’ of engagement) brings
them closer to the research but also brings the research
closer to them. In the case of translating research into
practice, the focus of this special issue, engaging the
public and other stakeholders is explicitly intended to
make the outcomes of translation relevant to its con-
stituency of users [31].
Epistemic and ontological considerations in engagement
In practice, engagement faces a number of challenges.
Achieving the aspirations of engagement is time-
consuming, expensive and often ‘thorny’ work. While mul-
tiple mechanisms for engagement already exist along the
spectrum from consultation to control, described originally
by Arnstein in 1969 [32], each has its shortcomings and
constraints. Some of the most well described engagement
mechanisms such as deliberative democracy, deliberative
forums, community meetings, consultations, surveys and
focus groups (all designed to contribute to decision mak-
ing) derive both rich and valuable understandings and pro-
duce concrete consensual outcomes. However, they can
also be costly, time consuming to implement and are avail-
able only to participants with the time and capacity to con-
tribute many hours or days to the engagement process, or
even more if significant travel from remote communities is
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required. The commitment of time, energy and presence
required of many engagement efforts is difficult, if not im-
possible, for many individuals. Following Irwin [33], we ask
do the ethical and practical aims of engagement hold only
if such undertakings are done perfectly? If engagement is
tokenistic-if engagement practices reinforce social inequal-
ities by including only those who already have more power-
ful voices or are disempowering because practices are
merely instrumental-can the expected outcomes be deliv-
ered or deliverable? [34] Moreover, ‘if there can be no perfect
engagement methodology should we abandon the project?’
To examine more closely the purported shortcomings and
constraints of engagement we turn to the typology offered
by Irwin and colleagues [33], who identify what amounts to
a ‘sport’ of engagement – critique with descriptions running
along fairly well trodden lines: contesting representativeness,
contesting communication and articulation, contesting im-
pacts and outcome, and contesting democracy. In this paper
we take to heart Irwin and colleagues’ argument that “the
(often implicit) evocation of the highest principles that en-
gagement might ideally fulfil can make it difficult to ac-
knowledge and pay serious attention to the varieties of
engagement that are very much less than perfect but still
somehow ‘good’ [p. 120]”. First, we use their typology as a
framework to examine (some) epistemic and ontological
rudiments of engagement and their implications for en-
gagement practice.
Epistemically, the critiques identified by Irwin and col-
leagues are based on a set of foundational assumptions.
The first of these, “Contesting representativeness” sug-
gests that notions of representation rest on foundational
assumptions which hold that representation of large
populations, or even of discrete communities, is inher-
ently desirable and epistemically or methodologically
possible. Critiques of engagement methods, therefore,
often round on the sampling techniques that were used;
to question whether the right proportions of the right
groups of individuals were included in the engagement
exercise. To explore this further we take a short detour
into sampling methodology.
From a methodological perspective representation raises
two critical questions: (1) Does the inferential process in a
particular setting actually require representativeness? (2)
Even if it is inferentially desirable can representativeness,
in practice, be achieved? The first question arises regularly
both in quantitative bioscience research and in qualitative
research. In the public health setting, for example, if you
wish to estimate the prevalence of type-2 diabetes in a
given population in order to determine the resources re-
quired to maintain a viable service for that population,
then the representativeness of the sample – relative to the
target population – is crucial to extrapolating the estimate
obtained in the sample to generate the implied prevalence
in the target population. Here, the required inference is
quantitative and could be obtained by integrating the het-
erogeneous prevalence of type-2 diabetes across many
population subgroups carefully weighting the integration
for how common each population-subgroup may be.
However, the relevant population-subgroups are often un-
observed – or unobservable-and the inferred prevalence
in the target population then relies on the implicit weights
reflected in the unknown distribution of subgroups in the
sample and in the target population. If those are different,
then extrapolation of the sample estimate to the general
population may be flawed – potentially badly so. In con-
trast, in contemporary bioscience, for example in design-
ing major biobanks, the framing of the primary scientific
question to be addressed often takes the form: is there any
meaningful association between the observed incidence of
a disease in a study (e.g. new cases of type-2 diabetes) and
the observed distribution of a determinant (maybe a vari-
ant V of gene G) in that same study? Crucially, the esti-
mated association in the sample makes no assumption of
representativeness-it is simply the ‘observed association in
the sample’. In that setting, representativeness only be-
comes of potential relevance if we try to relate this answer
to what it might mean at a general population level. Fur-
thermore, a problem will only arise if the magnitude of
the association itself varies markedly between population
subgroups: e.g. if variant V of gene G exhibits a strong
positive association with the disease in some population
subgroups, little or no association in others, and maybe
even a negative association in yet others. Although this is
scientifically possible, it is likely that the heterogeneity be-
tween population subgroups of such an association will be
less marked than variation in the prevalence of a disease
between population subgroups. Although it is theoretically
possible for a genetic variant that causes a disease in one
population subgroup to protect against that same disease
in another subgroup, such eventualities are rare. In conse-
quence, provided a sample is of adequate size, it is unlikely
that the weak effect of ‘non-representativeness’ alone
could convert a null or negative association in the general
population to a clearly positive association in the sample
or vice versa. This has an important corollary: when repre-
sentativeness is not critical, deliberately designing a study
so as to ensure that a sample is representative may be sci-
entifically counter-productive if the same resources could
instead be put to creating a less representative sample
which is more efficient (e.g. deliberately oversampling
high-risk population subgroups). The fundamental mes-
sage is not that ‘representativeness’ is irrelevant but rather
that it is sometimes very important and sometimes of little
or no relevance-its importance is dictated entirely by the
context of the research question to be asked.
Expectations that engagement should be representa-
tive are based on a logic that individuals are or can be
representative of the population or community in
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which they reside or with which they identify. Address-
ing the second question above, methodologically, it is
probably not feasible to ever gather such a representa-
tive group. In practical and epistemic terms we can
never know whether the difference between the (ran-
domly) selected sample is so different to the population
as to make inferences flawed; i.e. to formally demon-
strate that ‘representativeness’ is important. This is in
part because, in keeping with the logical underpinning
of the need for sample representativeness in prevalence
studies, the key criteria defining the relevant subgroups
comprising a sample to be used for engagement will
often be ‘unobserved’ and may be ‘unobservable’. Po-
tential participants who are least likely to be involved
in such activities because of temporal, spatial, socio-
economic, psychological or emotional factors will likely
remain uninvolved if social, structural or other impedi-
ments remain unchanged, despite the best efforts to
over-sample or otherwise entice them into the process.
Recognising the difficulty of circumventing this prob-
lem, the pragmatic alternative for recruitment in en-
gagement is to accept the impossibility of attaining and
demonstrating ‘representativeness’ and instead to pur-
sue the benefits provided by saturation. Saturation is a
term most often used in the context of qualitative re-
search where data collection (interviews, ethnographic
observations, interactions, documents) ceases at some
point after which no new themes, concepts, theoretical
components or other phenomena emerge from the
data. Rather than assume an infinite variety of possible
individuals and the implied boundlessness of perspec-
tives, saturation relies upon the rather more limited
variety of difference (or différance [35]), discourse [36],
social repertoires [37] and other markers of a socially-
constituted world that might be accessible through the
input of socially-situated individuals. To take this ser-
iously in engagement would mean to strive to recognise
difference, diversity and alterity – it is to continue to
ask the question ‘How could this be otherwise?’ [38]
until no new alternatives emerge. Where ‘this’ is the
phenomenon under consideration and ‘continuation’ is
enacted by reaching out to embrace difference. In prac-
tical terms saturation offers an alternative to random
(or quasi-random) selection of engagement participants
for representativeness. Rather than selecting on the
basis of a supposed ‘statistically representative’ sample,
purposive selection of potential participants until satur-
ation is reached may offer at least some access to the
alterity in a heterogeneous population. Crucially, as a
direct analogue to the quantitative setting (above), this
is both valid and useful in describing the complex inter-
relationships between ideas, understanding and view-
points in the engagement sample and making the valid
claim that these findings represent a useful snapshot of
the relationships that exist in the broader population.
Inferential problems only arise if attempts are then
made to make precise quantitative statements about
the frequency with which particular ideas might occur
in the broader population or about the strength of
the association between different ideas. The basis
of purposive selection and the determination of
saturation will necessarily be engagement specific.
And this brings us to a second, related, foundational
assumption.
Notions of representation implicitly defend founda-
tional assumptions of truth: that there is or might be
knowable, genuine, often ‘lay’ perspectives that we can
gain access to if only we use the right method or ap-
proach. As Irwin et al. [33] suggest, contesting communi-
cation method and articulation takes the form of
questions about what they call the “conditions of
speech”: how and whether participants in an engagement
exercise are able to articulate their views in “a proper
and meaningful manner”, including whether any mater-
ial presented to them is sufficiently balanced or un-
biased, too superficial or too complex, or framed to
produce certain outcomes. Central to such critiques is
the notion that there is an ideal, neutral or ‘objective’ set
of truths which can be articulated. Certainly, to actively
bias material or encourage extremist perspectives would
be unacceptable. But claims to objective truth are intrin-
sically problematic. Different notions of evidence and ex-
pertise make claims to different values (e.g. patient or
participant centredness) and position particular forms of
evidence (e.g. quantitative research data) as particularly
real, true or authoritative. Favouring one notion of evi-
dence and expertise over others narrows the epistemic
landscape by side-lining incompatible or contradictory
notions. The purpose in seeking ‘public’ views is often to
counter dominant views about a particular phenomenon,
especially those which may reproduce social inequalities
or other disadvantage. In the dialectic of powerful/less
voices and perspectives, the scientist is contrasted to re-
search participant, doctor to patient, government to citi-
zen. Addressing power relations is politically important
work but if a commitment to verity simply results in
truth-contests this work may be counter-productive; if,
for example, privileged access to ‘truth’ is seen to be the
province of one set of actors alone.
Attempts to achieve consensus, such as in deliberative
forms of engagement, aim to avert the potential stalemate
of competing truths. But the implicit focus on consensus,
even by contesting it, may potentially miss a key compo-
nent of the “conditions of speech”. Language (following
Austin, Foucault, Butler and others) is active. Language is
not merely representational, expressing well or poorly
some underlying truth or giving access (or not) to some
alternative perspective [39]. When we speak, we
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accomplish a range of actions. The perspectives we offer
and the values or discourses we draw upon bring into be-
ing certain versions of the world. They construct or enact
the social, but they do more than that. The ‘truths’ so con-
structed lay out the boundaries of the possible. A world in
which multiple publics voices are heard is fundamentally
different to one in which those same voices are absent or
suppressed. While public voices may still be marginalised,
the very possibility of engagement can arguably act as a
form of the conduct of conduct [40, 41]: scientists, doctors
and governments police their own practices on the under-
standing that those practices may be scrutinised.
The active character of language is not restricted to en-
actment but also of situated action; that is, bringing about
certain actions in relationship. As individuals, we produce
and co-produce our ‘selves’ as well as our worlds. We
present ourselves – or in Butlerian terms [42, 43] ‘perform’
ourselves – as certain types of people (e.g. in terms of gen-
der, ethnicity, expertise). We act to ‘save face’ [44, 45], espe-
cially in interactions which may challenge our ‘selves’, and
we warrant some actions or outcomes over others. Under-
standing language as performative leads us to two particular
considerations in terms of engagement. First, that represen-
tation itself (in the form of participants’ views or perspec-
tives within engagement practices) cannot be taken simply
or straightforwardly as depictions of truth or fact. This is
not to say that these representations are untrue or not
firmly held as beliefs, but rather that they construct certain
world views, often with particular value commitments. All
contributions, whether by participants or organisers, in an
exercise of engagement are produced from specific subject
positions which may change in different settings or be de-
ployed for different effects; this is as true of the most senior
collaborator as of those less powerfully positioned. It is
these constructs (of world and self) that are so enormously
powerful analytically, but which are often overlooked in en-
gagement practice. By establishing certain truths or values
as normative (what ‘should be’), the implications of what
can be, what is made possible in practice within the provi-
sions of these truths or values are also laid out, These are
undoubtedly worthy of analytic attention. The second con-
sideration is that these world views and value commitments
themselves implicate certain actions or outcomes. The cri-
tiques identified by Irwin et al. [33] as contested impact and
outcomes are undoubtedly recognisable in the oft voiced
claim that a particular engagement exercise has had no im-
pact. While it may be true (a material reality) that none of
the recommendations of a particular engagement exercise
have been implemented, it is unlikely that there has
been no effect, even if this is in ways that are unex-
pected or difficult to discern. Engagement practi-
tioners do well to look also to these unintended effects
as evidence of influence and to actively follow the pos-
sibilities and opportunities they present. Though not
all unintended outcomes will be as wished, some just
might be: take for example, the deliberative commu-
nity engagement exercise undertaken prior to the es-
tablishment of the Mayo Clinic Biobank which
resulted in the establishment of an ongoing Commu-
nity Advisory Board to provide advice, review policy
and participant materials, and provide input on com-
plex policy issues [22].
These ontological considerations of engagement prac-
tice and its impact bring us to the final strand of the com-
mon challenge described by Irwin and colleagues:
contesting democracy. The question ‘What is democracy?’
can certainly be considered an epistemic issue – forests
have been felled in presenting potential answers – and in
the same way that foundational concepts of truth are epi-
stemically constraining, so too are concepts of democracy.
But democracy is also a profoundly ontological issue: it is
something we do. Therefore rather than contesting defini-
tions of democracy or the opportunity cost of not picking
the ‘right’ one, the authors take the position that the en-
actment of something called democracy in achieving the
pragmatic aspirations of engagement, in and with transla-
tional research, is rather less important than doing some-
thing that might or might not achieve such lofty ideals.
To return to the question of this section ‘if there can be
no perfect engagement methodology should we abandon
the project?’ We suggest not. It is impossible (and perhaps
folly to try) to conceive of a single mechanism that would
suit all (potential) engagement settings, purposes and com-
munities. Instead, we offer here an approach that attempts
to address problems of representation and epistemic foun-
dationalism using a newly developed methodology that
seeks to maintain focus on the question, ‘How could it be
otherwise?’ We embrace alterity by offering an approach
that we believe affords the possibility of engagement where
spatial and temporal constraints are present, and which
relies on saturation as a method of ‘keeping open’ the pos-
sible considerations that might emerge from that engage-
ment. We also address the ontological challenges by
introducing an analytic element to the engagement process.
However, as will become evident, the method we describe
here is not an alternative that should be viewed as address-
ing all concerns about existing approaches to engagement.
Rather it is an approach that may provide a useful comple-
ment to existing methods and indeed borrows from some
of those methods in its realisation. We are intentionally
catholic in our embracing of multiple engagement and ana-
lytic methodologies.
Methods
The ECOUTER engagement method
The ECOUTER (Employing COnceptUal schema for
policy and Translation Engagement in Research) [46]
methodology is our response to the epistemic and
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ontological considerations discussed above. ECOUTER
offers an alternative ontology for and of engagement
without claiming to solve all of the challenges of engage-
ment. It is instead anticipated that ECOUTER will com-
plement and work in combination with other existing
approaches. Taken from the French verb ‘to listen’,
ECOUTER is an engagement approach that uses inter-
active mind-mapping – in low or high-tech formats – to
enable stakeholders to draw upon and explore their own
knowledge (we do not assume individual knowledge is
static or complete), to consider other relevant knowledge
and to interact on topics of shared concern. ECOUTER
recognises that many forms of expertise must be drawn
upon to ensure that decision making about research pol-
icy, governance, priorities and practice is robust, timely
and appropriate; further, it recognises that decisions
made about publicly funded research must be aligned
with social needs and values in order to realise their op-
timal translation into societal benefit. ECOUTER does
not assume that all contributions made in an engage-
ment exercise are themselves (or become via the engage-
ment process) prima facie evidence. Instead, participant
contributions, or first order constructs (participant pro-
duced), are subject to qualitative forms of analysis so as
to derive second order constructs (researcher produced)
that then form a conceptual model and related recom-
mendations. These are then fed back to stakeholders for
further refinement.
In its online form, ECOUTER incorporates know-
ledge exchange by enabling online access to external in-
formation sources. While many other engagement
mechanisms support engagement they can also con-
strain the range of possible understandings by using
pre-determined categories or may intentionally or inad-
vertently circumscribe discussion through the particular
framework used or assumptions imposed. ECOUTER
uses mind-mapping techniques to ‘open up’ engage-
ment, iteratively and organically. It explicitly supports
the inductive identification and exploration of new
ideas or topics. Although all approaches to engagement
sacrifice some utility or depth, ECOUTER aims to find
a balance between breadth, accessibility and user-
determination of the scope of engagement.
In practice, an ECOUTER exercise comprises four
stages: Stage 1 – engagement and knowledge exchange;
Stage 2 – analysis of mindmap contributions; Stage 3 – de-
velopment of a conceptual schema (i.e. a map of concepts
and their relationships); and Stage 4 – iterative feedback,
refinement and development of recommendations where
appropriate. Once completed, the mindmap is analysed it-
eratively using established qualitative techniques (e.g. the-
matic analysis or discourse analysis). The ECOUTER
analysis is not dependent on the means of data collection.
A conceptual schema, a map of concepts and their
relationships, is developed collaboratively. The results are
further discussed with the participants or, where participa-
tion is fleeting and anonymous, with participants from
similar stakeholder communities. Finally, the conceptual
schema(s) and feedback iterations form the basis of recom-
mendations for research, governance, practice and/or pol-
icy. In this paper we describe the first three stages of the
ECOUTER process, primarily using the experience of the
‘HeLEX’ ECOUTER (E3, one of five ECOUTER pilots, E1-
E5, described below) as a worked example. The final part
of an ECOUTER has not yet been undertaken for any of
the pilots and therefore is not addressed in detail here.
The ‘HeLEX’ ECOUTER (E3) was conducted during an
academic conference in June 2015 (E3) and asked “Transla-
tion and emerging technologies: what are the social, ethical
and legal issues?” Hosted by HeLEX (helex@dph.ox.ac.uk)
and led by the ELSI2.0 Collaboratory (https://elsi2workspa-
ce.tghn.org/), a community of scholars interested in the
Ethical, Legal and Social Implications (ELSI) of genetics and
genomics, the stated aim of Translation in Healthcare con-
ference, June 2015, was to “[bring] together a wide range of
voices to discuss and think more deeply about the techno-
logical, legal, ethical, and social challenges raised by new
technologies in healthcare … to capture the energy and free
flow of ideas that usually only occurs in the coffee breaks of
most conferences”1. ECOUTER was one of the methods
used in the conference to facilitate discussion and gather
the range of perspectives of delegates.
Results
Stage 1: Engagement and knowledge exchange
ECOUTER offers face-to-face and online modes of en-
gagement to support participation by a broad range of
people. An ECOUTER exercise begins by posing a cen-
tral question and typically seeds the mindmap with a
small number of initial themes/sub-questions as well as
links to materials in the relevant evidence base where
possible. Participants then draw upon their own know-
ledge of cognate issues to respond to and contribute
ideas to a mindmap, including links to additional evi-
dence (though the process does not assume either type
of evidence to be complete). The ECOUTER team re-
cords the evolving mindmap data at various stages, mon-
itors for (in) appropriate activity, and alerts participants
of end dates. In the online form of an ECOUTER exer-
cise, participants may access the mindmap at a time that
suits them and as often as they wish; input is entirely an-
onymous to both contributors and facilitators of the
mindmap. In its face-to-face form, a booth is typically
set up in a high traffic area and staffed with ECOUTER
facilitators, who interact with participants and help them
capture their ideas and thoughts on a mindmap using
tablets and laptops or on a wall using Post-It notes.
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During the lunch break on day two of the Translation
conference (E3), an ECOUTER exhibition space was set
up in a high traffic location and staffed by 7 members of
the D2K research group, including a videographer. The
exhibition space was equipped with three laptops pro-
viding access to the online mindmapping website as well
as two 60” monitors, one displaying a live version of the
mindmap as it evolved and the other for delegates to ex-
plore the same mindmap in detail on a big screen. Tech-
nical details about the establishment of the ECOUTER
mindmap, for online and offline modes, are beyond the
scope of this paper and are available elsewhere [47, 48].
The mindmap [see Additional file 1: Figure S1: ECOU-
TER mindmap and Additional file 2: ECOUTER mind-
map output] began with a central question reflecting the
conference theme and was pre-seeded with six questions
developed by MJM and JTM based on key issues raised
by speakers in the first plenary session and designed to
provoke comment. During the ECOUTER, participants
drew on their own understandings and often their own
research but were not otherwise asked to link out to ex-
ternal evidence as would normally be the case. Instead,
the external evidence base providing the counterpoint
for participant reflection consisted of the presentations
delivered in plenary on the first day of the conference.
Given the setting, numerous “micro-discussions” took
place between participants and facilitators. Results from
these exchanges were added to the mindmap by D2K
members with participants’ permission. Approximately
two thirds of 119 conference delegates who were regis-
tered on the day stopped by the exhibition stand to dis-
cuss the ECOUTER method as well as the questions
posed on research translation. A total of 37 entries were
made in the mindmap over approximately 75 min, with
a small number of participants contributing more than
one entry and a large number jointly contributed single
entries. The setting made complete anonymity unlikely
and facilitators were able to see what some participants
wrote. Nonetheless, the map displayed was anonymous.
Stage 2: Analysis of mindmap contributions
Stage 2 of the ECOUTER involved analysing the first
order constructs placed on the mindmap (i.e. those pro-
duced by the participants in their contributions to the
mindmap). While it might be argued that such con-
structs should speak for themselves (and indeed the raw
mindmap is included as Figure 1 and a list of the contri-
butions as Figure 2), in practice participants’ efforts to
summarise their thoughts for inclusion in the mindmap
typically reflect an imperfect process which requires
some unpacking on the part of those doing the analysis.
A preliminary analysis of the content of the mindmap
was presented by MJM in plenary session on the final
day of the conference. Following the conference, MJM
and JTM each subsequently analysed the mindmap en-
tries thematically before working iteratively until agree-
ment was reached on top level themes and sub-themes
using the constant comparative method [49]. This pre-
liminary analysis was then discussed during data analysis
sessions (MJM, JTM, AT, MB, CO) where first order
constructs (those produced by participants in the mind-
map) were interrogated and their meaning clarified.
Analysis was supplemented by the micro-discussions
participants engaged in with facilitators as the mindmap
was being populated. The analysis here is intentionally
descriptive and strongly tied to the empirical material.
While any broadly thematic or content-based form of
analysis could be used in Stage 2, we did not want to
move too far from the data itself in order that the next
stage of analysis could be directly informed by our expli-
cation of the first order constructs. This analysis com-
prised Stage 2 of ECOUTER exercise and is shown in
Additional file 3: Analysis of participant contributions in
an ECOUTER – first order constructs. Stage 2 of the
ECOUTER process demonstrated that participants
viewed translation as a complex process which included
a range of stakeholders who themselves represented a
broad range of perspectives and experiences that could
contribute to translation.
Stage 3: Development of a conceptual schema
Stage 3 of the ECOUTER method comprised further
analysis of the first order constructs of the participants.
We first looked to the construction of certain objects
(e.g. translation) and subjects (e.g. patient, scientist):
this type of analysis is closest to Foucaultian forms of
discourse analysis [39, 50–52]. Taking the position that
the values expressed in language are (as claimed of lan-
guage itself [42, 53–55]) performative, we examined the
implications (or effects) of the epistemic and non-
epistemic values (i.e. knowledge-related and socio-
ethical values, assumptions and standpoints) called
upon by conference delegates to describe the social,
ethical, political or legal issues for translation in health-
care. In using this particular combination of analysis we
are deliberately intending to address the epistemic and
ontological foundations we discussed earlier. However,
any form of analysis which goes beyond ‘face value’ rep-
resentation would be workable, though it should prefer-
ably be reflexive and identify its own epistemic and
ontological commitments. The analysis was used to
produce second order constructs (researchers’ con-
structs) and thereby build the conceptual schema, a
‘map’ of concepts and their relationships. The analysis,
described in Additional file 4: ECOUTER conceptual
schema – second order constructs, presents an interre-
lated trio of concepts we call Perspectives, Processes and
People.
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When considered in its entirety, the second order con-
ceptual schema demonstrates the ways in which the
ECOUTER methodology facilitated engagement during
the conference and opened up the subject of translation
in healthcare to wider examination beyond what was
said by the conference speakers. ECOUTER offered dele-
gates a forum for challenging the perspectives dominant
in scholarly frameworks and provided the means to en-
gage the cross section of delegates representing a variety
of interests in the field of translation. Moreover, the
ECOUTER helped ‘open up’ the discourses embedded in
the conference programme by challenging and advan-
cing ideas on how the process of translation happens. In
particular, delegates underscored the ways in which
emerging healthcare technologies are themselves a
highly ‘peopled’ phenomena, that is, one which is pro-
foundly grounded in human actions and relationships.
While some of the contributions to the mindmap were
also heard in the plenary sessions (both in specific pre-
sentations and in general Q&A exchanges), ECOUTER
amplified the dialogue among the delegates by offering
the opportunity to elaborate and expand beyond the
confines of the presentations, especially to junior aca-
demics who may have been reluctant to contribute their
ideas in plenary and other sessions.
Stage 4: Feedback, refinement and development of
recommendations
As noted above, we have not yet completed a full cycle
of the ECOUTER method and therefore do not present
a ‘worked’ Stage 4. In practice, Stage 4 could be deployed
using a number of existing deliberative or other engage-
ment approaches [7–9, 11, 16, 20, 28, 56–68]. In these
cases, the analysis in Stages 2 and 3 would form part of
the material upon which to reflect or deliberate.
Discussion
Piloting ECOUTER
The ECOUTER methodology has been – or is being
– piloted in five settings. Completed pilots have been
conducted with: the international ELSI community on
the topic of trust in data linkage (E1); the general
public on the use of personal medical records in re-
search (E2); delegates of an academic conference (E3),
the focus of this paper; and, researchers attending the
closing workshop of a multi-year European research
project to develop tools and methods facilitating data
sharing and biobanks (E4). The final ECOUTER pilot
(E5), is currently being used as a tool for engaging
with birth cohort participants as they attend whole-
day data collection clinics (2015–2017) around the
age of 24 years.
Each pilot has contributed to the development of
ECOUTER both in terms of delivery and analysis. E1,
the ‘P3G ECOUTER’, was conducted entirely online over
a 5 week period in September/October 2014 under the
auspices of P3G (Public Population Project in Genomics
and Society) at McGill University, Canada. The purpose
was to explore innovative mechanisms to build trust in
human health research biobanking. The ECOUTER
started with the question, What are the ethical, legal
and social issues related to trust in data linkage? Exist-
ing ELSI-related distribution lists were used to extend
approximately 175 invitations to stakeholders: 58 ‘ELSI
stakeholders’ in 11 countries (across Europe, Africa,
North and South America) registered to participate. E1
received just over 100 contributions and confirmed the
proof of concept for use of ECOUTER to facilitate dis-
cussions within a stakeholder community distributed
over a large non-contiguous geographic area.
E2, the ‘Shopping Centre ECOUTER’ tested ECOU-
TER as a tool for public engagement at the local level.
The topic was the use of personal health records for re-
search, following the then recently abandoned initial
rollout of the care (dot) data initiative in the English
NHS. On a single day in November 2014, a booth was
set up in a large urban shopping centre in the UK offer-
ing members of the public tablet computers and a large
screen monitor with which to consider the question,
Your medical records: handover or hands off? Seven fa-
cilitators initiated micro-discussions with over 100
members of the public, as a result of which 83 contri-
butions were made to the mind map. Shopping Centre
ECOUTER demonstrated the efficacy of the ECOUTER
methodology when conducted face-to-face and on a
topic involving experiential expertise. Given their close
proximity timewise and their similarities of topic, the
results of the Shopping Centre and P3G ECOUTERs
were analysed jointly, revealing a high degree of con-
ceptual overlap. Despite differences in the two originat-
ing questions, multiple intersecting themes emerged
yielding a conceptual schema comprising four areas:
definitions and boundaries; oversight mechanisms;
threats; and new knowledge. Nonetheless, it was signifi-
cant that some issues were emphasised more by the
public Shopping Centre ECOUTER participants: con-
cern about confidentiality and anonymity; concern
about exploitation for profit; and, support for data used
for research. ECOUTER enabled engagement and facili-
tated the surfacing of diverse points of view from stake-
holder communities of differing ‘status’.
E3, the ‘HeLEX’ ECOUTER, through which we explore
the methodology in this paper, is described in detailed
above.
Technical limitations (i.e. the unknown room layout/
availability of power points, etc., plus the logistical diffi-
culties of transporting display equipment to another
country) in the fourth pilot (E4) meant this one-day
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ECOUTER was conducted using Post-It notes to record
the discussions. The event was the final meeting of a
5 year European funded consortium, BioSHaRE
(www.bioshare.eu/), at which project participants were
invited to consider results from a formal evaluation of
new data sharing tools produced by the project [69]. In-
dividuals were invited to review a print copy of key find-
ings from the first two stages of the evaluation
(interviews and a survey) presented in a mindmap form.
They were then asked to consider the question, Bio-
SHaRE tools: Where to now? Responses were written on
Post-It notes and attached to a wall in the lunch/break-
out area of the workshop venue. The ‘BioSHaRE ECOU-
TER’ unfolded primarily during breaks in the meeting as
participants gathered for refreshments. Of the 118
people attending the event, we counted 112 actively en-
gaged with the ECOUTER team and a total of 117 Post-
It notes were contributed to the map. Analysis of the
results indicated broad coherence between the findings
and of the evaluation. Participants shared concerns for
usability challenges, data access, and the need to address
ELSI-related barriers. What was perhaps most surprising
was the degree to which contributions to the BioSHaRE
ECOUTER emphasised different and often more positive
aspects of these issues, particularly the users’ perspective
(e.g. need for workshops using own data, tool integra-
tion, and user needs assessment) than present in the
evaluation which largely focused on the developers and
first users of the tools. E4 demonstrated the solution
building capacity of ECOUTER as the results led both to
the identification of recommendations grounded in par-
ticipant’s experiences and to the development of new
ideas and approaches for subsequent grant applications.
E5 is an ECOUTER underway since May 2016 with
participants in the UK Children of the 90s study, the
Avon Longitudinal Study of Parents and Children
(ALSPAC), in its 24+ data collection clinic (http://
www.bristol.ac.uk/alspac/). ‘Clinic ECOUTER’ is part
of ALSPAC’s commitment to participant engagement,
which has included, from 2006, a participant advisory
group called the Teenage Advisory Panel (TAP) and,
since 2013, the Original Cohort Advisory Panel [70].
Since the study’s inception a key governance and pol-
icy group, the ALSPAC Law and Ethics Committee
(ALEC), has included study participants with two par-
ent members and, from its establishment, two TAP
representatives. ALEC is now formally constituted to
include equal numbers of participant and non-
participant members and is currently chaired by by a
study participant. Clinic ECOUTER asks participants
attending ‘What areas would you like Children of the
90s to research?’ The data collection clinic occurs over
a 24 month period with ECOUTER running mid-
clinic. The long duration offers challenges for
engagement which ECOUTER is uniquely placed to
address (the temporal distance of participants) but
also offers the possibility of comparing different
ECOUTER modes. Participants are encouraged to
interact with a mindmap during breaks in their visits
but later in the data collection period, participants will
also be offered online access to the mindmap outside
of the clinic. Results will be analysed throughout the
contribution period meaning that the ECOUTER will
be iterative among the participants as they cycle
through clinic attendance and beyond. Changes in in-
teractions produced by different modes will be ana-
lysed to improve ECOUTER.
Doing ECOUTER
Beyond the ‘worked’ example presented here, informa-
tion on how to conduct an ECOUTER can be found
in two locations. Technical aspects of running an
event, including discussion of ongoing challenges such
as the limitations of using open source software, have
been published online [48], while a Wiki to support
facilitators with checklists and other practical docu-
mentation is available online and updated regularly.
Beyond this, facilitators have identified a number of
concerns and limitations from the five pilot events
discussed in this paper. First, both online and face-to-
face ECOUTERs require a high degree of regular
moderation in order to keep discussions active and
engaging. This is particularly true with ECOUTERs
involving interactive booths, where facilitators must
find ways to transfer the content of micro-discussions
to the mind map. Second, there is an ongoing issue
of identifying how many individuals eventually con-
tribute to an ECOUTER mind map. Equally, it can be
difficult at busy times to count how many individuals
visit a booth versus how many then go online. Accur-
ate figures for both total number of participants and
which contributions were made by whom will ultim-
ately be required as part of evaluating the exercise.
Third, there remain ethical aspects yet to be fully ad-
dressed, including how best to inform participants in
advance in face-to-face settings. Especially in the ex-
hibition setting (e.g. E2, E3 and E4) interactions with
facilitators can be somewhat brief; better systems are
needed to inform individuals about the process with-
out being overly time consuming. Finally, the ECOU-
TER method has not yet completed its intended final
cycle of feedback to participants. While aspects of
this were achieved in the BioSHaRE ECOUTER (E4),
the intention is to have participants (or a similar
stakeholder community) review more fully the con-
ceptual schema arising from analysis: we are currently
planning Stage 4 for E1/2.
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Conclusion
Where does ECOUTER ‘fit’ as an engagement strategy?
Finally, having outlined a range of epistemic and onto-
logical challenges to engagement and having presented
one particular methodology in response, what have we
produced? We have taken Irwin and colleague’s typ-
ology as an armature, though we doubt if it was ever
intended thus, to build the logics of ECOUTER.
Against representativeness we offer saturation as a
way of surfacing diverse ideas and discourses; rather
than discovery of static (or ‘underlying’) truths - views,
perspectives, voices; we suggest using mindmapping a
means of ‘opening up’ exploration; we consider the
contributions and interactions enacted in those mind-
maps as material for analysis; looking to the performa-
tive nature of language we propose looking to ‘how
things could be otherwise’, not how things should be
(for who might be the arbiter of such ‘shoulds’?) but
how things can be; and, moreover, how ‘democracy’ it-
self could be otherwise. And, a la Spranzi and Brunet
[23], what is interesting about participants’ contribu-
tions is the values they emphasise: while not the focus
of analysis in this paper, values will be central to our
consideration of trust and data linkage (E1 and 2). In
practical terms ECOUTER offers what we hope is an
affordable methodology which is flexible and access-
ible in a range of settings. What our pilots demon-
strate, beyond how much is still to be learned, is that
the method can elicit a range of new ideas and new
possibilities and that these can and do travel beyond
the dominant or prevailing discourses. But this is only
achieved by using qualitative analytic methods reflex-
ively. So, is this engagement or is this research?
ECOUTER is clearly not deliberative democracy:
though as we have noted Stage 4 may borrow from
those methods. And yet it is, as per Scott and col-
leagues description of deliberative democracy [24],
“more than simply summing up or aggregating opin-
ions in some co-ordinated fashion” (p.4). Does it, then,
sit within definitions [71, 72] of empirical ethics? Per-
haps, but not easily. To take Davies and colleagues
useful typology [72] it is neither purely dialogical nor
purely consultative; it is hybrid and, we suggest, per-
petually so. In contrast to the other hybrid forms of
empirical bioethics described by Davies et al., ECOU-
TER is founded on an antifoundationalist epistemol-
ogy and ontology, following Foucault [36, 40, 41, 73],
Bulter [43] and Woolgar [38], particularly it is con-
cerned with the situated [74] and relational [75] ethics.
Or perhaps, where a normative stance is deployed ana-
lytically, rhetorically, pragmatically or politically, it
may remain, as Ives’ quasi-foundational ‘reflexive bal-
ancing’ [76], open to revision, challenge and reassess-
ment. Refusing fixed truths, ECOUTER also refuses a
fixed nature. In order that it achieve its promise it
must remain flexible, adaptable and open. ECOUTER
will be formed and re-formed by the needs and cre-
ativity of those who use it.
Endnotes
1A programme of the conference is available at http://
www.ndph.ox.ac.uk/upcoming-events/translation-in-health-
care/conference-programme-2015-v53-with-sponsors-for-
website.pdf.
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